Skip to main content
Year archive

Macrogen, Inc. — 2020 filings

All 44 regulatory filings released by Macrogen, Inc. (038290) in 2020, sourced directly from the official regulator.

44 Filings
2020 Period
2020 filings (44)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
파생상품거래손실발생
Capital/Financing Update
2020-11-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-11-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-11-04 Korean
소송등의판결ㆍ결정(주주명부 열람 및 등사 가처분)
Legal Proceedings Report
2020-11-03 Korean
소송등의판결ㆍ결정(주주총회 소집허가)
Legal Proceedings Report
2020-11-03 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2020-11-02 Korean
소송등의제기ㆍ신청(경영권분쟁소송)
Legal Proceedings Report
2020-10-05 Korean
소송등의제기ㆍ신청(경영권분쟁소송)(주주명부 열람 및 등사 가처분)
Legal Proceedings Report
2020-09-23 Korean
투자판단관련주요경영사항(유방암, 난소암 환자의 분자유전학적 분별진단을 위한 체외분자진단제품(Axen BRCA Library Kit)의 의료기기 제조허가 반려)
Regulatory Filings
2020-09-14 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-08-25 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2020-06-25 Korean
투자판단관련주요경영사항(유방암, 난소암 환자의 분자유전학적 분별진단을 위한 체외분자진단제품(Axen BRCA Library Kit)의 의료기기 제조허가 신청)
Regulatory Filings
2020-06-04 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-05-25 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2020-05-25 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2020-05-06 Korean
투자판단관련주요경영사항(BRCA 유전자를 검출하기 위한 NGS 기반의 Axen BRCA Library Kit 제품의 임상시험결과)
Legal Proceedings Report
2020-04-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-04-10 Korean
유상증자결정(종속회사의주요경영사항)
Capital/Financing Update
2020-04-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-02 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
정기주주총회결과
AGM Information
2020-03-27 Korean
대표이사변경
Board/Management Information
2020-03-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2020-03-27 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-19 Korean
파생상품거래손실발생
Capital/Financing Update
2020-03-19 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information FY 2019
2020-03-19 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-06 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-03 Korean
주주총회집중일개최사유신고
AGM Information
2020-03-03 Korean
기타경영사항(특허권취득)(자율공시)(암줄기세포 특이적 바이오마커)
Regulatory Filings
2020-02-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2019
2020-02-13 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares
2020-01-10 Korean
신탁계약해지결과보고서
Transaction in Own Shares
2020-01-10 Korean